semaglutide fda weight loss Approves Oral Semaglutide: First GLP-1 Pill FDA-Approved Oral Semaglutide Pills for

CagriSema produced mean weight loss of 13.7% at 68 weeks compared to 3.4% with placebo, with an on-treatment estimate of 15.7%

Patients should inform their healthcare provider about all skincare products being used

Thats why we combed Reddit to find out what people are currently talking about in obesity and GLP-1 communities and asked the following medical experts to respond to readers most pressing questions: Kia Mitchell, MD Double board-certified family and obesity medicine physician and founder of the International Womens Obesity Network Marsha Novick, MD, FAAFP Spokesperson for The Obesity Society and board member of the American Board of Obesity Medicine Richele Corrado, DO, MPH Spokesperson for The Obesity Society and medical director, internist, and obesity medicine physician at Revolution Medicine, Health & Fitness Sherrie Singh-Bryan, PharmD, CDCES Clinical pharmacist and certified diabetic care and education specialist at Winn Army Community Hospital in Fort Stewart, Georgia Editors note: These interviews have been edited for length and clarity

Canadian patent lapsed